CANNAINVESTOR Magazine U.S. Privately Held Companies November 2017 | Page 80

Pennsylvania: An Attractive Market for Public Companies

The Pennsylvania medical marijuana opportunity attracted several outside consultants to the state and we identified two publicly traded companies focused on it.

In late March, American Cannabis Company, Inc. (AMMJ) announced that five of its active clients successfully applied in Pennsylvania. Two applied for a dispensary license, one applied for a cultivation license, and the other two applied for both a cultivation and dispensary license.

Last fall, Medicine Man Technologies (MDCL) announced that it had signed 10 new clients in the month of October. Of these new clients, five were based in Pennsylvania and we will continue to monitor developments around this opportunity for the company.

Learn More

Applicant scores can be found, www.health.pa.gov

To learn about Act 16, click here

Important Investor Disclosures

This report was authored by and is property of Technical420. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by Technical420 regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only